Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VACH

Voyager Acquisition Corp

Feb 06 • 04:00PM ET

10.68

0.00 0.00 %

Financial • Shell Companies • USA • NASD

Held by: CUSD

Scroll to Statements

Index	-	P/E	33.10	EPS (ttm)	0.32	Insider Own	20.00%	Shs Outstand	25.30M	Perf Week	0.09%
Market Cap	337.76M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	25.30M	Perf Month	0.38%
Enterprise Value	337.51M	PEG	-	EPS next Q	-	Inst Own	83.59%	Short Float	0.03%	Perf Quarter	1.52%
Income	10.21M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.06	Perf Half Y	2.69%
Sales	0.00M	P/B	1.32	EPS next Y	-	ROA	3.89%	Short Interest	0.01M	Perf YTD	0.09%
Book/sh	8.06	P/C	1351.04	EPS next 5Y	-	ROE	4.08%	52W High	10.99 -2.82%	Perf Year	6.59%
Cash/sh	0.01	P/FCF	-	EPS past 3/5Y	- -	ROIC	4.00%	52W Low	10.08 5.95%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	0.02% 0.05%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.01	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.54	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	71.93	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.54	EPS Q/Q	78.47%	SMA20	0.24%	Beta	-0.00	Target Price	-
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	-	SMA50	0.67%	Rel Volume	0.00	Prev Close	10.68
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	2.19%	Avg Volume	126.18K	Price	10.68
IPO	Sep 30, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	564	Change	0.00%

Jul-17-25 08:55AM	VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC (GlobeNewswire)
May-29-25 06:34PM	VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform (GlobeNewswire)
May-20-25 12:10PM	VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer (GlobeNewswire)
May-05-25 12:59PM	VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program (GlobeNewswire)
Apr-23-25 01:09AM	VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies (GlobeNewswire)

Voyager Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on December 19, 2023 and is headquartered in Houston, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VACH

Voyager Acquisition Corp

Upgrade your FINVIZ experience